What the new estimate shows
Nearly 82 percent of New York residents in the state’s measured group are up to date with breast-cancer screening recommendations, according to data announced Friday at the start of Breast Cancer Awareness Month. The estimate covers females ages 50 through 74 and marks the second consecutive year in which New York says it surpassed the national screening goal.
A high statewide rate is encouraging because mammograms can find breast cancer before symptoms appear, when treatment may be more effective. It should not be read as proof that access is equal in every community. Statewide averages can mask differences associated with insurance, income, geography, transportation, language, disability and trust in the health system.
Who should be screened
The U.S. Preventive Services Task Force recommends a screening mammogram every other year for women ages 40 through 74 at average risk. People at higher risk may need a different starting age, frequency or type of imaging. Family history, known genetic variants, prior chest radiation, breast density and earlier findings can all affect an individual plan.
New York’s announcement noted that screening guidance also applies to transgender men and nonbinary people assigned female at birth when they have relevant breast tissue and risk. Personal decisions should be made with a qualified clinician who can assess age, medical history and individual risk. A screening schedule is not the same as evaluating a new lump, skin change, nipple discharge or other concerning symptom, which warrants prompt medical attention.
The burden of disease
Breast cancer remains one of the most common cancers among women in New York. State officials said close to 18,000 New Yorkers are diagnosed each year and nearly 2,300 die from the disease. Those figures explain why screening rates matter, but screening is only one part of a broader system that includes diagnostic follow-up, timely treatment, survivorship care and support for patients and families.
A mammogram can produce false-positive results that require additional imaging or a biopsy, and screening can sometimes identify cancers that would not have caused harm during a person’s lifetime. Those limitations are among the reasons medical groups frame screening as a shared decision shaped by evidence and risk rather than a universal promise of benefit.
Coverage and access in New York
New York expanded insurance coverage for breast screening and diagnostic imaging in 2024 to align with nationally recognized guidelines. Coverage rules, however, vary with the kind of health plan and service, so patients should confirm benefits, network requirements and any recommended follow-up with their insurer and clinician.
For eligible uninsured residents, the New York State Cancer Services Program provides free breast-cancer screening and diagnostic services through local contractors. That program can help address a central barrier: screening has limited value if an abnormal result is not followed quickly by diagnostic care. Residents can contact the program through the state Department of Health to learn whether they qualify.
How to use the announcement
For people who are due or uncertain, the practical next step is to review the date and result of the last mammogram and ask a clinician what schedule fits. Patients should mention family history and any prior high-risk finding. Those with dense breasts may receive a notice after mammography and can discuss whether additional imaging is appropriate, understanding that supplemental tests also have benefits and drawbacks.
The state’s 82 percent estimate is best understood as a public-health benchmark, not personal clearance. It signals broad participation and provides a basis for targeting communities where gaps remain. The larger goal is not merely more tests, but timely, informed screening connected to high-quality diagnostic and treatment services for every New Yorker who needs them.
Sources: New York State screening announcement; U.S. Preventive Services Task Force recommendation; New York State Cancer Services Program. This article is general information, not medical advice. Reporting reviewed October 3, 2026.